Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2052149 | FEBS Letters | 2005 | 12 Pages |
Abstract
In recent years, we have witnessed the discovery of a new mechanism of gene regulation called RNA interference (RNAi), which has revitalized interest in the development of nucleic acid-based technologies for therapeutic gene suppression. This review focuses on the potential therapeutic use of RNAi, discussing the theoretical advantages of RNAi-based therapeutics over previous technologies as well as the challenges involved in developing RNAi for clinical use. Also reviewed, are the in vivo proof-of principle experiments that provide the preclinical justification for the continued development of RNAi-based therapeutics.
Related Topics
Life Sciences
Agricultural and Biological Sciences
Plant Science
Authors
Susan L. Uprichard,